Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17

Summary

The purpose of this study is to determine the efficacy and safety of donepezil hydrochloride (Aricept) in the treatment of the cognitive dysfunction shown by children with Down syndrome, aged 11 to 17.

Timeline

Start

2008-09

Primary completion

2008-11

Completion

2008-12

Outcome

Outcome not reported

Stopped: “Sufficient evidence of efficacy not met. Discontinuation not based on any safety concerns.”

Drugs

Indications